** Shares of pharmaceutical co Caplin Point Laboratories
fall as much as 1.8% to 591.10 rupees, their lowest since June
3, 2021
** Stock on track to fall for a fourth consecutive session,
if losses hold
** Caplin trading below its 50-day (673.05), 100-day
(704.10) and 200-day (725.69) simple moving avgs since Feb 21
** CAPL's relative strength index (RSI) seen below 30,
indicating that stock is oversold
** Caplin's moving average convergence and divergence (MACD)
line has been below the signal line since March 13, 2023,
suggesting bearish momentum
** Over 61,000 shares change hands, 0.6x the 30-day moving
avg
** As of last close, stock down ~16% this year, extending
its ~17% decline in 2022
(Reporting by Kashish Tandon in Bengaluru)
((Kashish.tandon@thomsonreuters.com))